Animal models of portal hypertension

World Journal of Gastroenterology

Volumn 12, Issue 41, 2006, Pages 6577-6584

  Abraldes, Juan G ^a   Pasarín, Marcos ^a   García Pagán, Juan Carlos ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cirrhosis; Nitric oxide; Portal vein

Indexed keywords

CARBON TETRACHLORIDE; DIMETHYLNITROSAMINE; PHENOBARBITAL; THIOACETAMIDE;

ASCITES; BILE DUCT LIGATION; BILIARY CIRRHOSIS; BUDD CHIARI SYNDROME; COLLATERAL CIRCULATION; COMMON BILE DUCT; DISEASE ASSOCIATION; DISEASE MODEL; EDITORIAL; ESOPHAGUS VARICES BLEEDING; HEPATOPULMONARY SYNDROME; HUMAN; KIDNEY DYSFUNCTION; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LUNG HEMODYNAMICS; MEDICAL LITERATURE; MESENTERY BLOOD FLOW; MOLECULAR MECHANICS; NONHUMAN; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPLANCHNIC BLOOD FLOW; STOMACH DISEASE; SYSTEMIC CIRCULATION; VASCULAR RESISTANCE; VEIN LIGATION;

EID: 33751272869     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i41.6577     Document Type: Editorial

References (82)

1. Vorobioff J, Bredfeldt JE, Groszmarm RJ. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983; 244: G52-G57
2. Vorobioff J, Bredfeldt JE, Groszmann RJ. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology 1984; 87:1120-1126
3. Groszmann RJ, Abraldes JG. Portal hypertension: from bedside to bench. J Clin Gastroenterol 2005; 39: S125-S130
4. Mullen KD, McCullough AJ. Problems with animal models of chronic liver disease: suggestions for improvement in standardization. Hepatology 1989; 9: 500-503
5. Sarin SK, Sabba C, Groszmann RJ. Splanchnic and systemic hemodynamics in mice using a radioactive microsphere technique. Am J Physiol 1990; 258: G365-G369
6. Fernandez M, Vizzutti F, Garcia-Pagan JC, Rodes J, Bosch J. Anti-VEGF receptor-2 monoclonal antibody prevents portalsystemic collateral vessel formation in portal hypertensive mice. Gastroenterology 2004; 126: 886-894
7. Iwakiri Y, Cadelina G, Sessa WC, Groszmann RJ. Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1074-G1081
8. Bosch J, Enriquez R, Groszmann RJ, Storer EH. Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model. Hepatology 1983; 3:1002-1007
9. Kroeger RJ, Groszmann RJ. Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model. Hepatology 1985; 5: 97-101
10. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 1985; 248: G618-G625
11. Witte CL, Tobin GR, Clark DS, Witte MH. Relationship of splanchnic blood flow and portal venous resistance to elevated portal pressure in the dog. Gut 1976; 17: 122-126
12. Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 1994; 20: 1359-1363
13. Colombato LA, Albillos A, Groszmann RJ. Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal- hypertensive rats. Hepatology 1992; 15: 323-328
14. Castaneda B, Debernardi-Venon W, Bandi JC, Andreu V, Perez-del-Pulgar S, Moitinho E, Pizcueta P, Bosch J. The role of portal pressure in the severity of bleeding in portal hypertensive rats. Hepatology 2000; 31: 581-586
15. Cahill PA, Foster C, Redmond EM, Gingalewski C, Wu Y, Sitzmann JV. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology 1995; 22: 598-606
16. Lozeva V, Montgomery JA, Tuomisto L, Rocheleau B, Pannunzio M, Huet PM, Butterworth RF. Increased brain serotonin turnover correlates with the degree of shunting and hyperammonernia in rats following variable portal vein steriosis. J Hepatol 2004; 40: 742-748
17. Abraldes JG, Iwakiri Y, Loureiro-Silva M, Haq O, Sessa WC, Groszmann RJ. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state. Am J Physiol Gastrointest Liver Physiol 2006; 290: G980-G987
18. Sarin SK, Groszmann RJ, Mosca PG, Rojkind M, Stadecker MJ, Bhatnagar R, Reuben A, Dayal Y. Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension. J Clin Invest 1991; 87:1032-1036
19. Sarin SK, Mosca P, Sabba C, Groszmann RJ. Hyperdynamic circulation in a chronic murine schistosomiasis model of portal hypertension. Hepatology 1991; 13:581-584
20. Morgan JS, Groszmann RJ, Rojkind M, Enriquez R. Hemodynamic mechanisms of emerging portal hypertension caused by schistosomiasis in the hamster. Hepatology 1990; 11: 98-104
21. Lee SS, Girod C, Braillon A, Hadengue A, Lebrec D. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium. Am J Physiol 1986; 251: G176-G180
22. Burns RC, Wu Y, Sitzmann JV. Role of cirrhosis in the hemodynamic response to hemorrhage in portal hypertension. Surgery 1995; 117: 488-493
23. Biecker E, Neef M, Sagesser H, Shaw S, Koshy A, Reichen J. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis. Liver Int 2004; 24: 345-353
24. Beck PL, Lee SS. Vitamin K1 improves survival in bile-duct-ligated rats with cirrhosis. J Hepatol 1995; 23: 235
25. Castaneda B, Morales J, Lionetti R, Moitinho E, Andreu V, Perez-Del-Pulgar S, Pizcueta P, Rodes J, Bosch J. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats. Hepatology 2001; 33: 821-825
26. Cho JJ, Hocher B, Herbst H, Jia JD, Ruehl M, Hahn EG, Riecken EO, Schuppan D. An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. Gastroenterology 2000; 118: 1169-1178
27. Aller MA, Lorente L, Alonso S, Arias J. A model of cholestasis in the rat, using a microsurgical technique. Scand J Gastroenterol 1993; 28:10-14
28. Aller MA, Duran M, Ortega L, Arias JL, Nava MP, Prieto I, Arias J. Comparative study of macro- and microsurgical extrahepatic cholestasis in the rat. Microsurgery 2004; 24: 442-447
29. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984; 65: 305-311
30. Franco D, Gigou M, Szekely AM, Bismuth H. Portal hypertension after bile duct obstruction: effect of bile diversion on portal pressure in the rat. Arch Surg 1979; 114: 1064-1067
31. Heller J, Shiozawa T, Trebicka J, Hennenberg M, Schepke M, Neef M, Sauerbruch T. Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats. Eur J Clin Invest 2003; 33: 1006-1012
32. Sikuler E, Buchs AE, Yaari A, Keynan A. Hemodynamic characterization of conscious and ketamine-anesthetized bile duct-ligated rats. Am J Physiol 1991; 260: G161-G166
33. Jimenez W, Claria J, Arroyo V, Rodes J. Carbon tetrachloride induced cirrhosis in rats: a useful tool for investigating the pathogenesis of ascites in chronic liver disease. J Gastroenterol Hepatol 1992; 7: 9097
34. Graupera M, Garcia-Pagan JC, Titos E, Claria J, Massaguer A, Bosch J, Rodes J. 5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes. Gastroenterology 2002; 122: 387-393
35. Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, Yoshida Y, Fukui K, Maeda N, Nishizawa H, Nagaretani H, Okamoto Y, Kihara S, Miyagawa J, Shinomura Y, Funahashi T, Matsuzawa Y. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 2003; 125: 1796-1807
36. Proctor E, Chatamra K. High yield micronodular cirrhosis in the rat. Gastroenterology 1982; 83: 1183-1190
37. Kobayashi N, Ito M, Nakamura J, Cai J, Gao C, Hammel JM, Fox IJ. Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology 2000; 31: 851-857
38. 4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats. Hepatology 2001; 34: 677-687
39. Constandinou C, Henderson N, Iredale JP. Modeling liver fibrosis in rodents. Methods Mol Med 2005; 117: 237-250
40. Sieber CC, Lopez-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993; 104: 1750-1754
41. Loureiro-Silva MR, Cadelina GW, Groszmann RJ. Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas. Am J Physiol Gastrointest Liver Physiol 2003; 284: G567-G574
42. Li X, Benjamin IS, Alexander B. Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality. J Hepatol 2002; 36: 488-493
43. Okuyama H, Nakamura H, Shimahara Y, Uyama N, Kwon YW, Kawada N, Yamaoka Y, Yodoi J. Overexpression of thioredoxin prevents thioacetamide-induced hepatic fibrosis in mice. J Hepatol 2005; 42: 117-123
44. Luo B, Liu L, Tang L, Zhang J, Ling Y, Fallon MB. ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats. Am J Physiol Gastrointest Liver Physiol 2004; 286: G294-G303
45. Popov Y, Patsenker E, Bauer M, Niedobitek E, Schulze-Krebs A, Schuppan D. Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFkappaB. J Biol Chem 2006; 281: 15090-15098
46. Laleman W, Vander Elst I, Zeegers M, Servaes R, Libbrecht L, Roskams T, Fevery J, Nevens F. A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited. Eur J Clin Invest 2006; 36: 242-249
47. Yeh CN, Maitra A, Lee KF, Jan YY, Chen MF. Thioacetamide- induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma. Carcinogenesis 2004; 25: 631-636
48. Veal N, Oberti F, Moal F, Vuillemin E, Fort J, Kaassis M, Pilette C, Cales P. Spleno-renal shunt blood flow is an accurate index of collateral circulation in different models of portal hypertension and after pharmacological changes in rats. J Hepatol 2000; 32: 434-440
49. Tsukamoto H, Matsuoka M, French SW. Experimental models of hepatic fibrosis: a review. Semin Liver Dis 1990; 10: 56-65
50. Jenkins SA, Grandison A, Baxter JN, Day DW, Taylor I, Shields R. A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat. J Hepatol 1985; 1: 489-499
51. Nanji AA. Animal models of nonalcoholic fatty liver disease and steatohepatitis. Clin Liver Dis 2004; 8: 559-874, ix
52. DeLeve LD, McCuskey RS, Wang X, Hu L, McCuskey MK, Epstein RB, Kanel GC. Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 1999; 29: 1779-1791
53. Sweat ER, Musicant ME, Annetts DL, Goodhead B, Orloff MJ. Production of hepatic outflow block and ascites with an ameroid constrictor. Surg Forum 1966; 17: 376-378
54. Orloff MJ, Daily PO, Girard B. Treatment of Budd-Chiari syndrome due to inferior vena cava occlusion by combined portal and vena caval decompression. Am J Surg 1992; 163: 137-142; discussion 142-143
55. Bhathal PS, Grossman HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol 1985; 1: 325-337
56. Zhang JX, Pegoli W Jr, Clemens MG. Enclothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 1994; 266: G624-G632
57. Graupera M, Garcia-Pagan JC, Abraldes JG, Peralta C, Bragulat M, Corominola H, Bosch J, Rodes J. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Hepatology 2003; 37: 172-181
58. Gupta TK, Toruner M, Chung MK, Groszmann RJ. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 1998; 28: 926-931
59. Yokoyama Y, Xu H, Kresge N, Keller S, Sarmadi AH, Baveja R, Clemens MG, Zhang JX. Role of thromboxane A2 in early BDL-induced portal hypertension. Am J Physiol Gastrointest Liver Physiol 2003; 284: G453-G460
60. Kamath PS, Tyce GM, Miller VM, Edwards BS, Rorie DK. Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension. Hepatology 1999; 30: 401-407
61. Noda S, Masumi S, Moriyama M, Kannan Y, Ohta M, Sugano T, Yamate J. Population of hepatic macrophages and response of perfused liver to platelet-activating factor during production of thioacetamide-induced cirrhosis in rats. Hepatology 1996; 24: 412-418
62. Hori N, Okanoue T, Sawa Y, Mori T, Kashima K. Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration. Dig Dis Sci 1993; 38: 2195-2202
63. McGregor DD, Smirk FH. Vascular responses in mesenteric arteries from genetic and renal hypertensive rats. Am J Physiol 1968; 214: 1429-1433
64. Sogni P, Sabry S, Moreau R, Gadano A, Lebrec D, Dinh-Xuan AT. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats. J Hepatol 1996; 24: 487-490
65. Job T, Granger DN, Benoit JN. Intestinal microvascular responsiveness to norepinephrine in chronic portal hypertension. Am J Physiol 1991; 260: H1135-H1143
66. Sieber CC, Groszmann RJ. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am J Physiol 1992; 262: G996-G1001
67. Chojkier M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. Am J Physiol 1981; 240: G371-G375
68. Theodorakis NG, Wang YN, Skill NJ, Metz MA, Cahill PA, Redmond EM, Sitzmarm JV. The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: studies in gene-knockout mice. Gastroenterology 2003; 124: 1500-1508
69. Mosca P, Lee FY, Kaumann AJ, Groszmann RJ. Pharmacology of portal-systemic collaterals in portal hypertensive rats: role of endothelium. Am J Physiol 1992; 263: G544-G550
70. Claria J, Jimenez W, Ros J, Rigol M, Angeli P, Arroyo V, Rivera F, Rodes J. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites [see comments]. Hepatology 1994; 20: 1615-1621
71. Claria J, Jimenez W, Ros J, Asbert M, Castro A, Arroyo V, Rivera F, Rodes J. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology 1992; 15: 343-349
72. Ros J, Claria J, Jimenez W, Bosch-Marce M, Angeli P, Arroyo V, Rivera F, Rodes J. Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis. Hepatology 1995; 22: 915-920
73. Albillos A, Colombato LA, Groszmann RJ. Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology 1992; 102: 931-935
74. Colombato LA, Albillos A, Groszmann RJ. The role of central blood volume in the development of sodium retention in portal hypertensive rats. Gastroenterology 1996; 110: 193-198
75. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-1157
76. Martinez-Prieto C, Ortiz MC, Fortepiani LA, Ruiz-Macia J, Atucha NM, Garcia-Estan J. Haemodynamic and renal evolution of the bile duct-ligated rat. Clin Sci (Lond) 2000; 98: 611-617
77. Jimenez W, Martinez-Pardo A, Arroyo V, Bruix J, Rimola A, Gaya J, Rivera F, Rodes J. Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis. Hepatology 1985; 5: 245-250
78. Lopez C, Jimenez W, Arroyo V, Claria J, La Villa G, Asbert M, Gaya J, Rivera F, Rodes J. Temporal relationship between the decrease in arterial pressure and sodium retention in conscious spontaneously hypertensive rats with carbon tetrachloride-induced cirrhosis. Hepatology 1991; 13: 585-589
79. Panes J, Casadevall M, Pique JM, Bosch J, Whittle BJ, Teres J. Effects of acute normovolemic anemia on gastric mucosal blood flow in rats: role of nitric oxide. Gastroenterology 1992; 103: 407-413
80. Panes J, Casadevall M, Fernandez M, Pique JM, Bosch J, Casamitjana R, Cirera I, Bombi JA, Teres J, Rodes J. Gastric microcirculatory changes of portal-hypertensive rats can be attenuated by long-term estrogen-progestagen treatment. Hepatology 1994; 20:1261-1270
81. Fallon MB, Abrams GA, McGrath JW, Hou Z, Luo B. Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome. Am J Physiol 1997; 272: G779-G784
82. Morales J, Moitinho, E, Abraldes JG, Fernandez M, Bosch J. Effects of the V1a vasopressin agonist F-180 on portal hypertension-related bleeding in portal hypertensive rats. Hepatology 2003; 38: 1378-1383